## ROST: Ross Stores, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_20 2.9% below STRENGTH zone (4.0-10.0%); PEG 3.00 fails VALUE criteria (<1.0); RSI 76 overbought. Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.1% MRS), overbought RSI (76).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($171.53)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 8, Bearish: 0)

**1. Could Ross Stores Stock Hit $200 by Christmas? Here Are 3 Reasons Analysts Think So**
- Source: Finviz | 20251205T130937 | Bullish | Relevance: 100%
- Analysts believe Ross Stores (NASDAQ: ROST) stock could reach $200 by Christmas, driven by strong fundamentals, positive analyst price targets, and a bullish technical setup. The company's Q3 2026 earnings beat expectations, leading to raised guidance and reinforcing investor confidence. Analysts maintain Buy ratings and price targets above $200, recognizing Ross's resilience in the retail sector, especially during economic shifts where consumers may "trade down."

**2. Ross Stores stock price target raised to $203 by TD Cowen on growth outlook**
- Source: Investing.com | 20251204T141023 | Bullish | Relevance: 100%
- TD Cowen has raised its price target for Ross Stores (NASDAQ:ROST) to $203 from $192, maintaining a Buy rating due to the off-price retailer's strategic transformation, improved marketing, and distribution enhancements. The firm's fiscal year 2026 same-store sales estimate is 3%, with an earnings per share estimate of $7.26, exceeding consensus expectations. Other analysts, including BofA Securities, Bernstein SocGen Group, and UBS, have also increased their price targets following strong third-quarter earnings.

**3. Ross Stores stock price target raised to $203 from $192 at TD Cowen**
- Source: Investing.com | 20251204T110851 | Bullish | Relevance: 100%
- TD Cowen has increased its price target for Ross Stores (NASDAQ: ROST) to $203 from $192, maintaining a Buy rating, citing the company's strategic transformation and strong business momentum. This follows Ross Stores' impressive Q3 earnings, with multiple analyst firms also raising their price targets, and a planned board chair succession.

**4. Ross Stores (NASDAQ:ROST) Hits New 52-Week High - Time to Buy?**
- Source: MarketBeat | 20251205T162858 | Bullish | Relevance: 100%
- Ross Stores (NASDAQ:ROST) recently hit a new 52-week high of $179.05, driven by strong quarterly earnings that surpassed expectations and positive analyst ratings. The company reported EPS of $1.58 against an expected $1.38 and revenue of $5.60B, a 10.4% increase year-over-year. While analysts maintain a "Moderate Buy" consensus with a $177.73 price target, some insiders have reduced their holdings even as institutional ownership remains high.

**5. Invesco Ltd. Purchases 406,073 Shares of Ross Stores, Inc. $ROST**
- Source: MarketBeat | 20251205T122330 | Bullish | Relevance: 100%
- Invesco Ltd. significantly increased its stake in Ross Stores, Inc. by purchasing 406,073 additional shares, bringing its total to 4,403,648 shares. Other institutional investors also adjusted their positions in the apparel retailer, with institutional ownership now standing at 86.86%. Following strong Q3 earnings and a revenue beat, analysts have maintained "buy" or "outperform" ratings, with a consensus price target of $180.00.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 11, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-21 | Citigroup | $188 | $171 | +10% |
| 2025-11-21 | Barclays | $183 | $164 | +12% |
| 2025-11-21 | Bernstein | $159 | $147 | +8% |
| 2025-11-21 | UBS | $169 | $163 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-21 | Citigroup | main | Buy |
| 2025-11-21 | Barclays | main | Overweight |
| 2025-11-21 | Bernstein | main | Market Perform |
| 2025-11-21 | UBS | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.00M) |
| Sells | 2 ($0.97M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 47.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.9% (-1.4%)
- JPMORGAN CHASE & CO: 8.0% (+55.4%)
- Blackrock Inc.: 7.6% (+3.1%)
- State Street Corpora: 4.3% (-1.2%)
- Primecap Management : 3.1% (-3.1%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 11 raises (avg +9%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 3.00 signals overvaluation risk, limited margin of safety. Forward P/E 25.0x stretched relative to 10% growth. Quality metrics strong (ROE 37%, ROA 11%). Analyst sentiment positive (11 raises, avg +9%). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $58.9B |
| Beta | 1.04 |
| 52W Range | $122.36 - $185.85 |
| Short Interest | 2.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.00 |
| Forward P/E | 25.0 |
| Current P/E | 27.5 |
| YoY Growth | 9.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 6.0% to 2.9% (-3.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.1pp (needs >4.0% for momentum thesis). MRS_5 (-0.4%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 5.3% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.66), confirming momentum. RSI overbought at 76, risk of mean reversion. OFD pattern: +SLN (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.94% (CS: 74) | Neutral |
| RSI_14 | 75.9 | Overbought |
| MACD Histogram | 0.66 | Bullish |
| vs SMA20 | 1.053x | Above |
| vs SMA50 | 1.104x | Above |
| vs SMA200 | 1.232x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $177.87
- **Stop Loss:** $171.53 (3.6% risk)
- **Target:** $184.21 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 157
- **Position Value:** $27,925.59
- **Portfolio %:** 27.93%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-03-05 (Est: $1.66)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $1.42 | $1.58 | +10.9% |
| 2025Q3 | $1.54 | $1.56 | +1.4% |
| 2025Q2 | $1.43 | $1.47 | +2.5% |
| 2025Q1 | $1.66 | $1.79 | +7.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*